Su Wang

Title: Innovations by Inventor Su Wang

Introduction

Su Wang is an accomplished inventor based in Schwenksville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. His work focuses on addressing critical health challenges through innovative solutions.

Latest Patents

Su Wang holds a patent for "Vaccines against clostridium difficile comprising recombinant toxins." This invention relates to recombinant toxin A (TcdA) and toxin B (TcdB) proteins that have been modified to substantially reduce or eliminate toxicity. The patent also covers vaccines and immunogenic compositions that utilize these recombinant toxins, as well as methods for inducing an immune response in patients. The invention includes the expression of these toxins in recombinant systems, specifically using the baculovirus/insect cell expression system.

Career Highlights

Su Wang is currently employed at Merck Sharp & Dohme Corp., where he continues to advance his research and development efforts. His work has the potential to significantly impact public health by providing effective vaccines against serious infections.

Collaborations

Su Wang collaborates with notable colleagues, including Jon Henry Heinrichs and Jean-Luc Bodmer. These partnerships enhance the research and development process, fostering innovation in vaccine technology.

Conclusion

Su Wang's contributions to vaccine development exemplify the importance of innovation in addressing health challenges. His work not only showcases his expertise but also highlights the collaborative efforts that drive advancements in biotechnology.